CPT code 82952 designates an additional laboratory glucose measurement performed after a standard glucose tolerance test with three specimens, typically following an extra oral glucose dose. This code captures a specific follow-up analytic step in glucose tolerance evaluation and is relevant to clinicians, laboratories, and payers because it affects test reporting, billing specificity, and clinical interpretation of glycemic responses.

Key national payers considered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage and payment policies for this service influence laboratory revenue cycles and patient cost-sharing, and they can vary by commercial plan and Medicare rules.

Readers will find a concise review of what CPT code 82952 represents, the clinical context of its use within glucose tolerance testing, and where the service is typically performed. The publication includes benchmarks for utilization and reimbursement where available, recent policy updates affecting laboratory billing, and practical notes on documentation and coding practices associated with glucose tolerance follow-up testing. Data not available in the input will be noted as such in corresponding sections.